Medley Nears ¥3 Billion Share Buyback Cap With Completion of Latest Repurchase

An update from Medley ( (JP:4480) ) is now available.

Medley has completed a share repurchase program authorized by its board in November 2025, buying back 22,100 common shares for ¥41.6 million via market transactions on the Tokyo Stock Exchange between March 1 and 2, 2026. This transaction forms part of a broader buyback framework allowing up to 1.5 million shares or ¥3.0 billion, under which the company has repurchased a total of about 1.39 million shares for roughly ¥3.0 billion, signaling active capital management and potential support for shareholder value.

The conclusion of this buyback tranche indicates Medley has nearly exhausted the approved repurchase ceiling while leaving open the possibility of future share repurchases as a flexible element of its capital policy. For investors, the scale and completion of the program underscore management’s willingness to deploy cash to optimize capital structure and potentially bolster earnings per share, while also reflecting confidence in the company’s prospects amid prevailing market conditions.

The most recent analyst rating on (JP:4480) stock is a Sell with a Yen1794.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

More about Medley

Medley, Inc. is a Japan-based company listed on the TSE Prime Market that operates in the healthcare and technology sector, offering digital platforms and services aimed at improving medical and healthcare efficiency. Its business focuses on leveraging online solutions to connect patients, medical institutions, and related stakeholders in the Japanese market.

Average Trading Volume: 316,389

Technical Sentiment Signal: Sell

Current Market Cap: Yen64.95B

See more insights into 4480 stock on TipRanks’ Stock Analysis page.